Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so familiar routine of online calls and deadlines has returned. But what can you do? After all, the world — such as it is — continues to spin. So why not give it a nudge with a delicious cup of stimulation? Our choice today is cinnamon hazelnut. Feel free to join us. Meanwhile, here are a few tidbits to help you as your latest journey gets under way. We hope you have a productive and fulfilling day and, of course, do keep in touch. We enjoy the feedback and suggestions…
Johnson & Johnson (JNJ) plans to ask federal regulators early this week to authorize a booster shot of its Covid-19 vaccine, The New York Times reports. The company is the last of the three federally authorized vaccine providers to call for extra injections, amid mounting evidence that at least the elderly and other high-risk groups need more protection. Federal officials are increasingly worried that the more than 15 million Americans who received the J&J vaccine face too high a risk of severe Covid-19. The U.S. Food and Drug Administration on Friday scheduled an Oct. 15 meeting for an expert advisory committee to discuss whether to authorize emergency use of a J&J booster shot.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
